Life-Sciences-UK.com
The British Life Sciences Web Portal

This is a free web portal for the life sciences in the UK and Ireland... » read more

Evox Therapeutics’ £69.2m Series C Led by Redmile Group (2021-02-18)
Financing round significantly oversubscribed by both new and existing investors Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome platform Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading...
Charles River Acquires Cognate BioServices for $875m in Cash (2021-02-17)
– Significantly Expands Charles River’s Scientific Capabilities in the High-Growth Cell and Gene Therapy Sector – – Combines Cognate’s Comprehensive Cell and Gene Therapy CDMO Capabilities to Establish an Integrated Solution from Discovery through CGMP Manufactu...
Centessa Launches with $250m Series A & New RnD Model (2021-02-16)
> Merger of 10 Privately Held Biotech Companies with Highly Validated Programs Led by Industry Leading Teams to Operate Under Centessa Umbrella > Company Founded by Medicxi with Financing Led by General Atlantic, and Co-led by Vida Ventures and Janus Henderson I...
Immunocore Appoints Ralph Torbay as Head of Commercial (2021-02-16)
> Ralph Torbay appointed Head of Commercial to spearhead the launch of tebentafusp > Dr. Roy S. Herbst appointed as a Non-Executive Director to the Board Immunocore Holdings plc (Nasdaq: IMCR), (or the “Company” or “Immunocore”), a late-stage biotechnology ...
Rentschler Establishes Rentschler ATMP Ltd. in Stevenage, UK (2021-02-11)
New enterprise, Rentschler ATMP Ltd., is part of continuous innovation at Rentschler Biopharma and supports ongoing strategic international expansion > Center of Excellence to address the gap in capacity and support for early-stage innovators in cell and gene th...
Rentschler Biopharma to Build New CAGT Capabilities in UK (2021-02-11)
- Rentschler Biopharma will establish their ATMP development and manufacturing capabilities at the Cell and Gene Therapy Catapult facility in Stevenage - Agreement confirms UK's global attractiveness for development of cell and gene therapies The Cell and G...
Quell Therapeutics Expands Series A with $35.7m to $84m (2021-02-11)
– Largest Series A in the Treg field – – Lead program is a first-in-class treatment targeting liver transplantation with engineered Treg cell therapy – – First program expected to enter the clinic in first half of 2022 – Quell Therapeutics Ltd (“Quell”),...
SpyBiotech Raises $32.5m Series A and Appoints Chairman (2021-02-10)
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development > SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug an...
Immunocore Announces Closing of $312.1m Aggregate Financing (2021-02-09)
Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial Public Offering, Full Exercise of Option to Purchase Additional ADSs and $15.0 Million Concurrent Private Placement Immunocore Holdings plc (Nasdaq: IMCR), a...
PepGen Appoints James McArthur as CEO (2021-02-04)
Seasoned biotech executive with deep experience and proven track record in successfully leading rare disease companies through rapid growth and development PepGen, a biotechnology company focused on transforming the care of patients with neuromuscular diseases...

Life-Sciences-UK.com is your doorway to the British and Irish life sciences!

[LSUK] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the UK and Ireland.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUK] is 100% Made in Germany!

» Start here with the latest News!

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)